Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 65862-044

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 65862-044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label- Principal Display Panel (10 mg/12.5 mg (30 Tablet Bottle))

NDC 65862-043-30 is a prescription medication containing lisinopril and hydrochlorothiazide in a tablet form with dosages of 10 mg/12.5 mg per tablet. It is distributed by Aurobindo Pharma USA, Inc, and made in India. This medication should be stored at a controlled temperature of 20° to 25°C (68° to 77°F) and protected from light and humidity. The prescribing information should be read before use.*

FDA Label Image

Package Label- Principal Display Panel (20 mg/12.5 mg (30 Tablet Bottle))

This is a description of a medication with the NDC code 65862-044-30. The medication is called Lisinopril and Hydrochlorothiazide Tablets, USP and is available through prescription only. Each tablet contains Lisinopril USP 20 mg and Hydrochlorothiazide USP 12.5 mg. The medication comes in a bottle with 30 tablets and is distributed by Aurobindo Pharma USA, Inc. The medication is manufactured in India and is labeled with a code of TS/DRUGS/19/1993. The prescribing information enclosed has the usual adult dosage. The medication should be stored at 20° to 25°C (68° to 77°F) in a controlled room and protected from excessive light and humidity.*

FDA Label Image

Package Label- Principal Display Panel (20 mg/25 mg (30 Tablet Bottle))

Lisinopril and Hydrochlorothiazide Tablets, USP with a strength of Lisinopril USP 20 mg and Hydrochlorothiazide USP 25 mg is a prescription-only medication. It is distributed by Aurobindo Pharma USA, Inc. This medication is typically used in adults and the recommended dosage should be followed as per the enclosed prescribing information. The medication should be stored at 20°C to 25°C (68°F to 77°F) and protected from excessive light and humidity. The provided NDC code for this medication is 65862-045-30.*

FDA Label Image

Lisinohydro-str1 (Lisinohydro Str1)

FDA Label Image

Lisinohydro-str2 (Lisinohydro Str2)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.